Difficult Myotomy Is Not Determined by Preoperative Therapy and Does Not Impact Outcome by Cowgill, Sarah M. et al.
Difficult Myotomy Is Not Determined by Preoperative
Therapy and Does Not Impact Outcome
Sarah M. Cowgill, MD, Desiree V. Villadolid, MPH,
Sam Al-Saadi, MD, Alexander S. Rosemurgy, MD
ABSTRACT
Objectives: The impact of preoperative endoscopic ther-
apy on the difficulty of laparoscopic Heller myotomy and
the impact of the difficulty of the myotomy on long-term
outcome has not been determined. This study was under-
taken to determine whether preoperative therapy impacts
the difficulty of laparoscopic Heller myotomy and
whether preoperative therapy or difficulty of myotomy
impacts long-term outcomes.
Methods: Since 1992, 305 patients, 56% male, median age
49 years, underwent laparoscopic Heller myotomy and
were prospectively followed. The difficulty of the laparo-
scopic Heller myotomy was scored by the operating sur-
geon for the most recent 170 consecutive patients on a
scale of 1 (easiest) to 5 (most difficult). Patients scored
their symptoms before and after myotomy using a Likert
scale from 0 (never/not bothersome) to 10 (always/very
bothersome).
Results: Before myotomy, 66% of patients underwent
endoscopic therapy: 33% dilation, 11% Botox, and 22%
both. Preoperative endoscopic therapy did not correlate
with the difficulty of the myotomy (PNS). Median fol-
low-up was 25 months. Regardless of the difficulty of the
myotomy, dysphagia improved with myotomy
(P0.0001). By regression analysis, the frequency and
severity of postmyotomy dysphagia correlated with nei-
ther preoperative endoscopic therapy nor the difficulty of
the myotomy.
Conclusions: Laparoscopic Heller myotomy improves
the frequency and severity of dysphagia. The difficulty of
laparoscopic Heller myotomy is not impacted by preop-
erative therapy, and neither preoperative therapy nor dif-
ficulty of the myotomy impact long-term outcome.
Key Words: Achalasia, Heller myotomy, Pneumatic dila-
tion, Botulinum toxin.
INTRODUCTION
Achalasia is defined by discoordinated or absent esopha-
geal peristalsis and abnormal lower esophageal sphincter
(LES) relaxation secondary to the destruction of the my-
enteric plexus of the esophagus. Essentially, the swallow-
ing process becomes progressively dysfunctional until pa-
tients affected by achalasia are unable to empty their
esophagus effectively. Against the functional obstruction
of the LES, the esophagus becomes increasingly dilated,
patulous and, at end-stage achalasia, can form a hugely
dilated serpiginous conduit. Presenting symptoms include
dysphagia, regurgitation, chest pain, weight loss, and,
occasionally, heartburn. No treatment will restore the mo-
tility of the achalasic esophagus, but various treatments
have been utilized over the years to relieve the functional
obstruction and reduce the pressure gradient across the
sphincter.
Broadly categorized, options for treatment of achalasia
consist of endoscopic or operative management, each
having the same goal of relieving the functional obstruc-
tion of the lower esophageal obstruction. Upper endos-
copy has been utilized to either dilate the LES with pneu-
matic balloons or as a vehicle for the injection of
botulinum toxin A (ie, Botox) into the LES. Pneumatic
dilation forcefully tears the LES and a postprocedure in-
flammatory response and subsequent fibrosis after the
tear will occur.1 Pneumatic dilation of the nonsurgical
therapies provides the most efficacious relief of symp-
toms, and gastroenterologists continue to undertake this
procedure because it is well tolerated, generally requires
no hospital stay, and is cost-efficient in the short-term.2,3
However, recurrence of significant symptoms are esti-
mated at greater than 50% in long-term follow-up.4,5 In-
jection of botulinum toxin into the LES inhibits calcium-
dependent release of acetylcholine from the nerve
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SCIENTIFIC PAPERterminals and has been popularized in the last 10 years by
many, including Parischa et al.6 While gastroenterologists
find the technique simple with few side effects, it provides
only short-term (eg, several months) relief for as few as
50%.2,7 Despite this, many patients undergo endoscopic
management of their achalasia for years before referral for
surgical management.
Laparoscopic Heller myotomy has been proven to be an
efficacious and durable therapeutic option for individuals
with achalasia.8–10 However, endoscopic therapy for
achalasia continues to be commonly undertaken despite
evidence that a laparoscopic Heller myotomy is the most
effective management for achalasia. This study was un-
dertaken to determine whether endoscopic therapy, in-
cluding pneumatic dilation or botulinum toxin injections,
or both, with their presumed effects on LES tissue planes
and provocation of reactive fibrosis, impacted difficulty of
or outcome after laparoscopic Heller myotomy. In addi-
tion, this study was undertaken to determine the impact of
the difficulty of the myotomy on long-term outcome after
myotomy. Our hypotheses were that endoscopic therapy
increased the difficulty of laparoscopic Heller myotomy,
preoperative endoscopic interventions negatively im-
pacted outcome after myotomy, and difficulty of myotomy
inversely correlated with long-term outcome.
METHODS
Achalasia was diagnosed in symptomatic adults by either
a timed barium esophagram or esophageal manometry.
The classic “bird’s beak” appearance of the distal esoph-
agus was noted on esophagrams, often in the presence of
esophageal spasm and dysmotility. Loss of esophageal
peristalsis with the failure of coordinated LES relaxation
was documented by manometry. Esophagogastroduode-
noscopy, often with concomitant endoscopic therapy (ie,
dilation or botulinum toxin injection), confirmed the lack
of mechanical obstruction. Any nonoperative (ie, endo-
scopic) interventions, including balloon dilation and bot-
ulinum toxin injections, undertaken before myotomy
were noted. Patient data collection and study design were
conducted in concordance with a protocol approved by
the Institutional Review Board of the University of South
Florida College of Medicine.
Before and after myotomy, patients scored the frequency
and severity of their symptoms by using a Likert scale: 0
(never/not bothersome) to 10 (always/very bothersome).
In addition, patients were asked to grade their overall
outcomes at each postoperative encounter as “excellent”
(complete symptom relief), “good” (greatly improved
symptoms), “fair” (slightly improved symptoms), or
“poor” (no improvement or worsening of symptoms) rel-
ative to before myotomy. In addition, they were asked to
grade their experience from very unsatisfying to very
satisfying and declare whether they would have the op-
eration again knowing what they know now.
Operative Technique
All patients underwent laparoscopic Heller myotomy. The
operation was undertaken using a 5-port technique, as
previously described.8,11 A 10-mm port was placed at the
umbilicus under direct visualization. A second 10-mm port
was placed with videoscopic guidance along the right
anterior axillary line at the subcostal margin and was used
to insert a fan retractor. This retractor lifted the liver away
from the stomach and gastroesophageal junction. The
main working port was a 10-mm port placed at the right
midclavicular line along the subcostal margin. Another
10-mm port was placed at the subxiphoid position,
through which a zero-degree laparoscope was ultimately
placed. Finally, a 5-mm port was placed along the left
subcostal margin to allow access for the assistant.
First, the gastrohepatic ligament was opened widely in a
stellate fashion by using an ultrasonic dissector. The dis-
section was then carried up and down the right and left
crura and into the mediastinum to adequately mobilize the
distal esophagus into the peritoneal cavity. It was gener-
ally unnecessary to divide short gastric vessels, but the
esophagus was freed circumferentially from the esopha-
geal hiatus. Once a sufficient length of esophagus had
been mobilized into the abdomen, the myotomy was
begun. Using hook cautery, the longitudinal fibers of the
esophagus were transected to expose the transverse mus-
cle fibers. The transverse fibers were divided adequately
cephalad and caudad to relieve the proximal and distal
extent of the esophageal outlet obstruction. The myotomy
was carried caudad onto the stomach to relieve the distal
extent of the obstruction. To confirm an adequate myot-
omy, intraoperative endoscopy was routinely undertaken.
An adequate myotomy was confirmed when the endo-
scope passed easily into the stomach, the gastroesopha-
geal junction opened easily with endoscopic air insuffla-
tion, and transillumination of the myotomized segment
confirmed muscle division well above and below the
Z-line without defects in the submucosa.
The difficulty of the myotomy was scored intraoperatively
by a single experienced surgeon. The scale of scores was
a continuum that ranged from 1 to 5, with “1” being easiest
and “5” being most difficult. Assignment of difficulty score
JSLS (2007)11:336–343 337was based on the degree of adherence of the longitudinal
and circular muscular fibers to the submucosa and the
difficulty of separating the transected muscle fibers off the
submucosa. An intraoperative esophagotomy, almost by
definition, occurred when the myotomy difficulty was
scored as a “5.”
Early in our experience, fundoplication after Heller myot-
omy was selectively constructed. A posterior fundoplica-
tion or anterior fundoplication was applied if a patulous
hiatal defect, a large hiatal hernia, or an esophagotomy
was noted. Later, anterior fundoplications were routinely
constructed following publication of a randomized trial
supporting application.12 If anterior fundoplication was
constructed, the anterior fundus was first sutured to the
left side of the esophagus, lateral to the myotomy. Then
the anterior fundus was sutured to the right side of the
esophagus, again lateral to the myotomy. Thereby, nearly
the entire myotomized esophagus was covered by the
anterior fundoplication. The anterior fundoplication was
tacked to the right crus to remove tension from the lower
esophagus and to prevent the fundoplication from coming
undone. The esophageal hiatus was then reconstructed
using 0-braided polyester suture. The fascia at each trocar
site was closed with monofilament absorbable sutures.
The skin was closed with paper strips.
Postoperative Management
With transfer out of the postanesthesia recovery unit,
patients underwent esophagography to assure adequate
esophageal emptying and absence of esophagotomy.
With prompt emptying and no leakage, patients were
started on liquid diets per os. Patients were discharged,
generally the next morning, with instructions to continue
a liquid diet until a follow-up visit in 1 to 2 weeks. At that
time, their diets were advanced to a more textured diet. If
the postoperative esophagram indicated poor esophageal
emptying, it was usually due to self-limited postoperative
edema that resolved within 24 to 48 hours. If evidence of
poor emptying did not resolve, the possibility of an in-
complete myotomy was considered.
Data Management and Statistical Analysis
With Internal Review Board approval, data were main-
tained on an Excel (Microsoft, Redmond, WA) spread-
sheet and analyzed by the Wilcoxon Matched Pairs Test or
Mann-Whitney U-test when appropriate using True Epistat
(Epistat Services, Richardson, TX) or GraphPad InStat
(GraphPad Software, San Diego, CA). Significance was
accepted with 95% confidence. Where appropriate, data
are presented as median, meanstandard deviation.
RESULTS
Since 1992, 305 patients have undergone laparoscopic
Heller myotomies at our institution and have been pro-
spectively followed. The difficulty of myotomy has been
scored intraoperatively in our last 170 consecutive pa-
tients, and the outcomes of these patients were studied.
Of the 170 patients studied, 96 (56%) were male and 74
(44%) were female. The median age of the 170 patients
was 49 years (range, 5017.9) (Table 1). Duration of
symptoms varied among patients stratified by difficulty of
myotomy (Table 1), but overall median duration of symp-
toms was 4 years (range, 78.6). Median follow-up after
myotomy for all 170 patients was 25 months.
Before myotomy, 112 (66%) of the 170 patients underwent
endoscopic therapy: 38 patients (22%) had both pneu-
matic dilation and botulinum toxin injection, 18 patients
(11%) underwent botulinum toxin injection alone, 56
(33%) patients underwent pneumatic dilation alone, and
58 patients (34%) had neither (Table 2).
Median length of stay for all patients was 1.0 day, (range,
2.84). Median length of stay for patients with myotomies
scored at “1” was 1 day, (range, 10.0), while for patients
with myotomies scored at “5,” it was 4 days (range,
42.6). Nonetheless, by regression analysis, hospital
Table 1.
Difficulty of Myotomy in 170 Patients With Achalasia Scored on a Scale of 1 to 5
Patient Characteristics Difficulty Score
1 2345
Number of Patients (M:F) 2 (2:0) 76 (38:38) 26 (15:11) 55 (35:20) 11 (6:5)
Age (years) 33 (33  0.0) 54 (53  18.6) 52 (54  18.6) 46 (43  15.7) 50 (50  13.2)
Duration of Symptoms (years) 1 (1  0.0) 5 (8  8.7) 4 (8  10.9) 2 (5  5.7) 9 (13  11.2)
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preoperative endoscopic therapy. Complications related
to the myotomies and inadvertent intraoperative events
did occur (Table 3). In those patients with myotomies
scored at “2”, no inadvertent esophagotomies were related
to the myotomy. Intraoperative esophagotomies occurred
in 4 patients with myotomies scored at “4,” and 3 intraop-
erative esophagotomies occurred in 3 patients with myot-
omies scored at “5.” The most severe complications oc-
curred in 2 patients who underwent concomitant
diverticulectomies at the time of myotomy. Though the
difficulty of myotomy was scored as “2” in both of these
patients, the diverticulectomy site staple lines leaked in
both on late esophagography. One of these 2 demon-
strated no leakage on repeat esophagography, but ulti-
mately developed pneumonia, respiratory failure, and ex-
pired after her family elected to withdraw care.
Symptoms of achalasia before myotomy, specifically, dys-
phagia, chest pain, and heartburn were essentially the
same for patients regardless of prior endoscopic dilation
or botulinum toxin injections and regardless of the diffi-
culty of myotomy score. By multivariable regression, none
of the symptoms correlated with endoscopic treatment or
difficulty of myotomy with the exception of heartburn
severity. Heartburn was more severe in patients who had
undergone both pneumatic dilation and botulinum toxin
before myotomy and in those who had not undergone
either (P0.05).
Regardless of the difficulty of myotomy, symptoms of
dysphagia frequency and severity improved with myot-
omy (P0.0001) (Figures 1 and 2). With the exception of
the 2 patients whose myotomies were scored at a difficulty
of “1,” heartburn frequency and severity significantly im-
proved after laparoscopic Heller myotomy regardless of
difficulty score (Figures 3 and 4). Chest pain frequency
and severity improved after laparoscopic Heller myotomy
only in those patients whose difficulty of myotomy was
scored at “2,” “3,” or “4.” Those patients at either end of
Table 2.
Difficulty Scores for 112 Treated With Endoscopic Pneumatic
Dilation and Botulinum Toxin Injections Prior to Laparoscopic
Heller Myotomy (N170)
Premyotomy Endoscopic
Therapy
Difficulty Score
1 2345
Total number of patients 1 51 19 34 7
Botulinum toxin only 1835 1
Dilation only 0 27 12 14 3
Botulinum toxin and Dilation 0 16 4 15 3
Table 3.
Complications Categorized by Difficulty Score. More
Inadvertent Esophagotomies Occurred With More Difficult
Myotomies
Difficulty
Score
Complication N
1 None 2
2
Pneumonia 1
Esophageal leak after concomitant
diverticulectomy
2
Death 1
Empyema 1
Delayed esophageal emptying 2
Pneumothorax with chest tube 2
Dysrhythmia 1
3
Leak 1
Pneumonia 1
4
Leak and empyema 1
Delayed esophageal emptying 2
Intraoperative esophagotomy 4
Urinary retention 2
5
Esophagotomy 3
Gastrotomy 1
Figure 1. Dysphagia frequency before and after laparoscopic my-
otomy. A Likert scale was used (0never to 10always).*P0.03,
before vs after myotomy, Wilcoxon matched-pairs test.
JSLS (2007)11:336–343 339the spectrum of difficulty did not experience a significant
reduction in the frequency or severity of symptoms of
chest pain after laparoscopic Heller myotomy. By regres-
sion analysis, the frequency and severity of postmyotomy
symptoms correlated with neither preoperative endo-
scopic therapy or with difficulty of myotomy (Figures 5,
6, 7, and 8).
Patients were asked at follow-up how they would grade
their symptom relief relative to before myotomy. Most
(67%) reported “excellent” symptom relief with symptoms
almost completely resolved. A smaller number (14%) re-
ported “good” results, with symptoms occurring less than
once per month. Fifteen percent noted that their symptom
improvement was “fair” with symptoms slightly improved.
Finally, only 4% noted “poor” outcomes with no symptom
improvement. Overall experience was reported by 89% of
patients to be “very satisfying” or “satisfying.” When pa-
tients were asked whether they would still have the op-
eration knowing what they now know, 92% would still
have the operation and only 7% reported that they would
not go through the operation again knowing what they
know now. By regression analysis, symptom resolution
did not correlate with difficulty score or preoperative
endoscopic treatment. Whether the patients would repeat
the operation knowing what they now know did correlate
with preoperative pneumatic dilation or botulinum toxin
injections and difficulty score.
Figure 2. Dysphagia severity before and after laparoscopic my-
otomy. A Likert scale was used (0not bothersome to 10very
bothersome). *P0.03, before vs. after myotomy, Wilcoxon
matched-pairs test.
Figure 3. Heartburn Frequency. Patients graded the frequency
of their heartburn before and after laparoscopic myotomy. A
Likert scale was used (0never to 10always). Patients were
then stratified by difficulty score. *P0.03, before vs. after my-
otomy, Wilcoxon matched-pairs test.
Figure 4. Heartburn Severity. Patients graded the severity of
their heartburn before and after laparoscopic myotomy. A Likert
scale was used (0Not Bothersome to 10Very Bothersome).
Patients were then stratified by difficulty score. *P0.03, before
vs. after myotomy, Wilcoxon matched-pairs test.
Figure 5. Dysphagia Frequency. The frequency of dysphagia
was the same before myotomy regardless of difficulty of myot-
omy or preoperative endoscopic treatment. A Likert scale was
used (0never to 10always).
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Few medical or surgical practitioners amass large experi-
ences with achalasia. Prior to advanced laparoscopic sur-
gical techniques, the first-line therapy was endoscopic
pneumatic dilation in preference to the more invasive
transthoracic or transabdominal cardiomyotomy, (ie,
Heller myotomy). With the advent of advanced minimally
invasive techniques, laparoscopic Heller myotomy has
proven to be most efficacious with tolerable morbidity for
patients with achalasia.10,11 However, there continues to
be some debate between medical and surgical camps
regarding the appropriate initial management of other-
wise healthy patients with achalasia. Patients with acha-
lasia are often referred for balloon dilation with a 60% to
95% short-term “success” rate quoted in the literature.4,13
Because of the small, but not insignificant risk, of esoph-
ageal perforation with pneumatic dilation, some practitio-
ners still inject “low-risk, low-yield” botulinum toxin as the
primary treatment for achalasia. This requires injection of
the neurotoxin in multiple areas of the gastroesophageal
junction. The gastroesophageal junction is precisely the
area of operative intervention in undertaking myotomy,
and after botulinum toxin injection, some obliteration of
anatomic planes in this area is to be expected. Despite the
potential consequences of injection and the lack of long-
term durability of botulinum toxin, patients continue to
receive this therapy, generally prior to myotomy.2,13 The
role for botulinum toxin injections for achalasia may be in
those patients who are poor operative risks with short life
expectancies. Herein, we present a large population of
patients who underwent preoperative endoscopic therapy
before laparoscopic Heller myotomy, were scored intra-
operatively for difficulty of myotomy based on tissue ad-
herence, and were examined for respective outcomes.
In this study of 170 patients with achalasia who under-
went laparoscopic Heller myotomy, all underwent scoring
of difficulty of myotomy intraoperatively. A significant
majority of those studied had either endoscopic pneu-
matic dilation or botulinum toxin injections as primary
treatment before surgical intervention. Certainly the diffi-
culty of myotomy for most patients was scored in the
middle of the spectrum, but small numbers were scored as
the most technically easy (“1”) myotomy and as the most
technically difficult (“5”) myotomy. Possible bias in scor-
ing the difficulty of the myotomy intraoperatively must be
acknowledged. However, the scoring was undertaken by
a single experienced surgeon who assigned a score based
on defined technical parameters. Difficulty score and/or
endoscopic treatment with botulinum toxin or pneumatic
Figure 6. Dysphagia Severity. The severity of dysphagia was the
same before myotomy regardless of the difficulty of myotomy or
preoperative endoscopic treatment. A Likert scale was used
(0not bothersome to 10very bothersome).
Figure 7. The frequency of dysphagia improved regardless of
difficulty of myotomy or preoperative endoscopic treatment. A
Likert scale was used (0not bothersome to 10very bother-
some).
Figure 8. The severity of dysphagia uniformly improved regard-
less of the difficulty of myotomy or preoperative endoscopic
treatment. A Likert scale was used (0not bothersome to
10very bothersome).
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with the exception of heartburn severity. In addition,
endoscopic treatment before myotomy had no bearing on
the difficulty of the subsequent myotomy.
Regardless of the difficulty of the myotomy, all patients
noted a significant improvement in symptom frequency
and severity with few exceptions. Those exceptions were
notable for lack of dysphagia or heartburn symptom im-
provement in the patients whose myotomies were scored
as “1.” However, there were only 2 patients with myot-
omies scored as “1.” In addition, chest pain frequency or
severity did not improve significantly for either those with
the easiest myotomies or for those with the most techni-
cally difficult myotomies for reasons that are not entirely
clear.
Complications or inadvertent events occurred regardless
of difficulty score. Certainly, an inadvertent esoph-
agotomy was a more heavily represented complication in
those myotomies scored with a “4” or a “5,” but the 2 most
morbid complications occurred in the 2 patients with
myotomies scored at “2.” These 2 patients had contained
staple-line leaks at concomitant diverticulectomy sites.
One of these individuals developed an empyema from a
late pneumonia and required decortication, but he ulti-
mately left the hospital. The other was a frail, malnour-
ished octogenarian who developed a small delayed leak
at the staple line of the diverticulectomy with no imme-
diate ramifications, but ultimately developed respiratory
failure and expired more than 30 days postoperatively
when the family elected to withdraw support. These
costly complications are undoubtedly secondary to the
necessary aggressive dissection into the mediastinum re-
quired to resect the diverticulum as well as the addition of
a staple line upon the esophagus.
Some have noted that preoperative endoscopic interven-
tions in patients with achalasia influence the difficulty and
subsequent morbidity of laparoscopic Heller myot-
omy.14,15 Horgan et al15 noted significant difficulty in iden-
tifying submucosal planes in over 50% of the patients who
had been treated with botulinum toxin injections preop-
eratively. Inadvertent esophagotomies occurred in 2 of
their 15 patients treated with botulinum toxin, and this
was felt to reflect the extensive obliteration and fibrosis
present at the gastroesophageal junction secondary to the
injections. These same investigators found no correlation
with difficulty and preoperative pneumatic dilation. A
similar study found that those patients who transiently
responded to botulinum toxin injections had the most
technically difficult myotomies because of a fibrotic reac-
tion at the gastroesophageal junction, but patients who
had experienced no relief with botulinum injections and
those who had previous pneumatic dilations had excellent
results.16 Similarly, a recent report notes significantly more
intraoperative esophagotomies and morbidities regardless
of endoscopic mode of preoperative therapy for achala-
sia.14 In addition, these same authors attribute their overall
failure rate of 17% after Heller myotomy to preoperative
endoscopic therapy, because failure after laparoscopic
Heller myotomy was doubled in those who underwent
endoscopic therapy preoperatively.
Large numbers of patients with achalasia are treated by
endoscopic means before surgical intervention. We have
previously noted that degree of fibrosis in the esophageal
muscle was not correlated with preoperative endoscopic
therapy.17 Preoperative endoscopic therapy before lapa-
roscopic Heller myotomy did not determine the difficulty
of the operation or long-term outcomes in our patients.
Though laparoscopic Heller myotomy is a great “salvage”
procedure after failed endoscopic therapy, we continue to
encourage its “first-line” application because of long-term
efficacy.
CONCLUSION
Despite the efficacy and durability of laparoscopic Heller
myotomy for achalasia, patients continue to be treated
with endoscopic botulinum injections or pneumatic dila-
tion preoperatively. Regardless, preoperative endoscopic
interventions for achalasia do not correlate with the diffi-
culty of myotomy or subsequent outcomes after laparo-
scopic Heller myotomy, and furthermore, the difficulty of
the myotomy does not impact the long-term outcome after
myotomy.
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